Form 4 Tracker
Marshall Fordyce

Director, PRESIDENT AND CEO · 11 filings · Latest: Sep 15, 2026

Vera Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
VERA
Marshall FordyceDirector, PRESIDENT AND CEOSep 15, 2026
Sale
$37.0018,500$684.5K235,244
VERA
Marshall FordyceDirector, PRESIDENT AND CEOSep 15, 2026
Option Exercise
$2.9018,500$53.6K253,744
VERA
Marshall FordyceDirector, PRESIDENT AND CEOSep 2, 2026
Sale
$35.1218,500$649.6K235,244
VERA
Marshall FordyceDirector, PRESIDENT AND CEOSep 2, 2026
Option Exercise
$2.9018,500$53.6K253,744
VERA
MARSHALL FORDYCE—Sep 2, 2026
Proposed Sale
$34.2364,750$2.2M—
VERA
Marshall FordyceDirector, PRESIDENT AND CEOJul 7, 2026
Sale
$42.3046,250$2.0M235,244
VERA
Marshall FordyceDirector, PRESIDENT AND CEOJul 7, 2026
Option Exercise
$2.9046,250$134.0K281,494
VERA
Marshall FordyceDirector, PRESIDENT AND CEOJun 23, 2026
Sale
$37.9318,500$701.8K235,244
VERA
Marshall FordyceDirector, PRESIDENT AND CEOJun 23, 2026
Option Exercise
$2.9018,500$53.6K253,744
VERA
Marshall FordyceDirector, PRESIDENT AND CEOMay 12, 2026
Sale
$36.7418,500$679.7K235,244
VERA
Marshall FordyceDirector, PRESIDENT AND CEOMay 12, 2026
Option Exercise
$2.9018,500$53.6K253,744
VERA
Marshall FordyceDirector, PRESIDENT AND CEOJul 7, 2026
Sale
$42.3046,250$2.0M151,994
VERA
Marshall FordyceDirector, PRESIDENT AND CEOJun 23, 2026
Sale
$37.9318,500$701.8K198,244
VERA
MARSHALL FORDYCE—Jun 23, 2026
Proposed Sale
$38.4374,000$2.8M—
VERA
Marshall FordyceDirector, PRESIDENT AND CEOMay 12, 2026
Sale
$36.7418,500$679.7K216,744
VERA
MARSHALL FORDYCE—May 12, 2026
Proposed Sale
$36.6118,500$677.3K—
VERA
Marshall FordyceDirector, PRESIDENT AND CEOApr 14, 2026
Sale
$44.0522,951$1.0M235,244
VERA
MARSHALL FORDYCE—Apr 14, 2026
Proposed Sale
$43.7122,951$1.0M—
VERA
Marshall FordyceDirector, PRESIDENT AND CEOFeb 23, 2026
Sale
$41.9816,925$710.6K257,163
VERA
MARSHALL FORDYCE—Feb 23, 2026
Proposed Sale
$42.0416,600$697.8K—

Page 1 of 2

Next →